Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Other Accumulated Expenses of $55000.0 for Q1 2026, down 91.3% on a QoQ basis from $632000.0 in Q4 2025, and down 31.25% year-over-year from $80000.0 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $55000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 31.25% year-over-year to $55000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55000.0 (down 31.25% YoY) and the FY2025 annual result came in at $632000.0, up 1244.68% from the prior year.
- Other Accumulated Expenses was $55000.0 for Q1 2026 at Eledon Pharmaceuticals, down from $632000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $705000.0 in Q2 2024 and bottomed at $13000.0 in Q2 2022.
- A 5-year average of $127176.5 and a median of $50000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses surged 1755.26% — and 2025, when it plunged 95.89%.
- Eledon Pharmaceuticals' Other Accumulated Expenses stood at $112000.0 in 2022, then slumped by 60.71% to $44000.0 in 2023, then rose by 6.82% to $47000.0 in 2024, then soared by 1244.68% to $632000.0 in 2025, then tumbled by 91.3% to $55000.0 in 2026.
- Business Quant data shows ELDN's Other Accumulated Expenses at $55000.0 in Q1 2026, $632000.0 in Q4 2025, and $52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Eledon Pharmaceuticals | 404.17 Mn | 404.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 39,000.00 |
| Jun 30, 2021 | 17,000.00 |